Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.65), $0.20 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $75.4 million versus the consensus estimate of $76.5 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.